Cornell-linked dog DNA test developer Embark Veterinary raised the capital in a round led by SoftBank Vision Fund 2 at a $700m post-money valuation.

Imec.xpand has returned to back a series B round for sleep diagnostic developer Onera Health, spun out of Imec.

IP Group is among the investors backing the DDR cancer therapeutics developer’s latest round, which took its total funding to $320m.

SoftBank has contributed to a $350m private placement supporting the health screening provider's reverse takeover.

M Ventures, Novartis Venture Fund and Pfizer Ventures are among the investors backing the DDR cancer therapeutics developer’s latest round, which took its total funding to $320m.

Icahn School of Medicine spinout Sema4 has completed a reverse merger with CM Life Sciences to begin trading on the Nasdaq Global Select Market.

Denso took part in a $71m series D round for artificial intelligence technology provider Blaize while inflammatory disease drug developer Aristea closed a $63m Novo and Arena-backed round.

The newly formed RxCapital has made its first investment, in metabolic and cardiovascular disease drug developer Rivus Pharmaceuticals' $35m series A round.

Craig Cimini will be the remaining managing director at health insurer Cigna's corporate venture capital subsidiary.

SAP.io took part in email software provider Sedna's $34m series B round while Byju's picked up BCC-backed learning app developer Toppr in a deal reportedly sized at about $150m.